NCT05950841View on ClinicalTrials.gov

Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

February 3, 2025

Study Completion Date

February 3, 2025

Conditions
Iron-deficiency
Interventions
DRUG

Low dose IHAT

Once daily dose of 1 capsule (100mg per capsule IHAT) and Once daily dose of 1 capsule (carob flour)

DRUG

High Dose IHAT

Twice daily dose of 1 capsule (100mg per capsule IHAT)

DRUG

Carob flour

Twice daily dose of 1 capsule (carob flour)

Trial Locations (1)

4006

RDC Clinical Pty Ltd, New Farm

All Listed Sponsors
collaborator

Nemysis Ltd

INDUSTRY

lead

RDC Clinical Pty Ltd

INDUSTRY

NCT05950841 - Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman | Biotech Hunter | Biotech Hunter